Nuveen
NVAX icon

Nuveen’s Novavax NVAX Stock Holding History

Nuveen’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26M Buy
346,415
+22,909
+7% +$205K ﹤0.01% 2328
2026
Q1 		$2.63M Sell
323,506
-5,256
-2% -$47.6K ﹤0.01% 2162
2025
Q4 		$2.21M Hold
328,762
– – ﹤0.01% 2254
2025
Q3 		$2.85M Sell
328,762
-14,031
-4% -$109K ﹤0.01% 2151
2025
Q2 		$2.16M Sell
342,793
-49,877
-13% -$330K ﹤0.01% 2271
2025
Q1 		$2.52M Buy
392,670
+15,702
+4% +$130K ﹤0.01% 2243
2024
Q4 		$3.03M Sell
376,968
-47,651
-11% -$459K ﹤0.01% 2214
2024
Q3 		$5.36M Buy
424,619
+61,233
+17% +$791K ﹤0.01% 1957
2024
Q2 		$4.6M Buy
363,386
+96,748
+36% +$973K ﹤0.01% 1993
2024
Q1 		$1.27M Hold
266,638
– – ﹤0.01% 2595
2023
Q4 		$1.28M Buy
266,638
+5,076
+2% +$31.1K ﹤0.01% 2614
2023
Q3 		$1.89M Buy
261,562
+10,104
+4% +$80.7K ﹤0.01% 2316
2023
Q2 		$1.87M Sell
251,458
-51,313
-17% -$404K ﹤0.01% 2380
2023
Q1 		$2.1M Buy
302,771
+43,976
+17% +$405K ﹤0.01% 2310
2022
Q4 		$2.66M Buy
258,795
+90,624
+54% +$1.6M ﹤0.01% 2254
2022
Q3 		$3.06M Sell
168,171
-6,426
-4% -$278K ﹤0.01% 2167
2022
Q2 		$8.98M Sell
174,597
-19,646
-10% -$1.02M ﹤0.01% 1576
2022
Q1 		$15.3M Sell
194,243
-64,653
-25% -$5.77M ﹤0.01% 1362
2021
Q4 		$37M Sell
258,896
-193,884
-43% -$33.3M 0.01% 851
2021
Q3 		$93.9M Buy
452,780
+44,391
+11% +$9.78M 0.03% 448
2021
Q2 		$86.7M Sell
408,389
-84,568
-17% -$15.5M 0.03% 518
2021
Q1 		$89.4M Buy
492,957
+7,858
+2% +$1.57M 0.03% 493
2020
Q4 		$54.1M Sell
485,099
-11,842
-2% -$1.26M 0.02% 658
2020
Q3 		$53.8M Buy
496,941
+10,852
+2% +$1.32M 0.02% 555
2020
Q2 		$40.5M Buy
486,089
+296,579
+156% +$11.3M 0.02% 631
2020
Q1 		$2.57M Buy
189,510
+107,517
+131% +$910K ﹤0.01% 2059
2019
Q4 		$326K Sell
81,993
-14,750
-15% -$64K ﹤0.01% 2993
2019
Q3 		$486K Buy
96,743
+9,126
+10% +$49.9K ﹤0.01% 2956
2019
Q2 		$513K Buy
+87,617
New +$690K ﹤0.01% 2998
2017
Q2 		– Sell
-670
Closed -$17K – 1238
2017
Q1 		$17K Sell
670
-175
-21% -$4.81K ﹤0.01% 1344
2016
Q4 		$21K Sell
845
-48
-5% -$1.4K ﹤0.01% 1503
2016
Q3 		$37K Hold
893
– – ﹤0.01% 1377
2016
Q2 		$130K Sell
893
-15
-2% -$1.72K ﹤0.01% 1267
2016
Q1 		$94K Sell
908
-45
-5% -$4.83K ﹤0.01% 1361
2015
Q4 		$160K Sell
953
-38
-4% -$5.85K ﹤0.01% 1460
2015
Q3 		$140K Hold
991
– – ﹤0.01% 1492
2015
Q2 		$221K Buy
991
+68
+7% +$12K ﹤0.01% 1518
2015
Q1 		$153K Hold
923
– – ﹤0.01% 1529
2014
Q4 		$109K Sell
923
-36
-4% -$3.76K ﹤0.01% 1568
2014
Q3 		$80K Buy
959
+115
+14% +$10.4K ﹤0.01% 1549
2014
Q2 		$78K Buy
844
+69
+9% +$6.06K ﹤0.01% 1560
2014
Q1 		$70K Hold
775
– – ﹤0.01% 1554
2013
Q4 		$79K Buy
775
+253
+48% +$17.9K ﹤0.01% 1534
2013
Q3 		$33K Buy
+522
New +$29.4K ﹤0.01% 1459

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Nuveen's NVAX Position: Q2 2026 in Review

Nuveen increased its Novavax (NVAX) stake by 7.1% in Q2 2026, buying an estimated $205K and bringing the position to 346,415 shares worth $3.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2328.

Nuveen first reported a position in NVAX in Q3 2013 and has held it in 44 quarters since. The position peaked at $93.9M in Q3 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Nuveen held 346,415 shares of Novavax worth $3.26M as of Q2 2026.
  • Nuveen bought 22,909 Novavax shares in Q2 2026, an estimated $205K.
  • Novavax made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2328 holding.
  • Nuveen first reported a position in Novavax in Q3 2013 and has held it in 44 quarters since.
  • Nuveen's Novavax position peaked at $93.9M in Q3 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.